A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease
Authors:
Open Access
- 2 November 2021
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 16 (1) , 1-12
Abstract
Background and purpose: Sickle cell disease (SCD) is a collection of rare inherited blood disorders affecting approximately 100,000 people in the U.S. and 20–25 million people globally. Individuals with SCD experience recurrent episodes of severe and unpredictable pain that are caused by vaso-occlusive crises (VOCs), a hallmark of the disease. VOCs are the primary cause of hospitalization in SCD, result in missed workdays and school days, and decrease quality of life (QoL). Although VOCs cause significant burden in the lives of individuals with SCD, there is no synthesis on the frequency of VOCs in the real world. This systematic literature review sought to identify literature describing the frequency of VOCs experienced by individuals with SCD in real-world settings. Methods: MEDLINE and 6 congresses were searched (date range: January 1, 2000 to June 30, 2020). Studies were reviewed independently by two researchers. Studies assessing frequency or prevalence of VOCs or VOC-related outcomes were included. Results: Of 1438 studies identified in the search, 52 met pre-specified inclusion and exclusion criteria. Reported frequency of VOCs varied widely ranging from a mean or median of 0 VOCs/year to 18.2 VOCs/year. The proportion of patients experiencing ≥ 3 VOCs/year ranged from 4 to 67% and the proportion of patients experiencing ≥ 5 VOCs/year ranged from 18 to 59%. Measures of VOC severity were limited, with 13 studies considering frequency of complicated VOCs and only 1 study reporting duration of VOC episodes. Conclusions: This is the first study to systematically assess published evidence pertaining to VOCs in real-world settings. Reported VOC frequency in real-world settings varied widely, with a majority of studies only considering VOCs managed in an inpatient or outpatient setting. Studies that considered VOCs managed at home reported a higher frequency of VOCs, suggesting that many studies may underestimate the frequency of VOCs. This systematic literature review (SLR) highlights the need for consistent reporting of (1) self-reported VOCs, including those managed at home, (2) definitions of VOCs, (3) complicated VOCs, and (4) duration of VOC episodes in literature.Keywords
This publication has 50 references indexed in Scilit:
- Challenge of Managing Sickle Cell Disease in a Pediatric Population Living in Kinshasa, Democratic Republic of Congo: A Sickle Cell Center ExperienceHemoglobin, 2014
- A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force ReportValue in Health, 2014
- Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern IndiaPediatric Blood & Cancer, 2013
- Management of sickle cell disease from childhood through adulthoodBlood Reviews, 2013
- Hydroxyurea treatment of children with hemoglobin SC diseasePediatric Blood & Cancer, 2012
- Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell diseaseHaematologica, 2012
- Inhibition of cell adhesion by anti–P-selectin aptamer: a new potential therapeutic agent for sickle cell diseaseBlood, 2011
- DNA polymorphisms at the BCL11A , HBS1L-MYB , and β- globin loci associate with fetal hemoglobin levels and pain crises in sickle cell diseaseProceedings of the National Academy of Sciences, 2008
- Asthma is associated with acute chest syndrome and pain in children with sickle cell anemiaBlood, 2006
- Acute admissions of patients with sickle cell disease who live in Britain.BMJ, 1987